CAS: 346640-08-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCF-642 REF: IN-DA00C6L0CAS: 346640-08-2 | 97% | 67.00 €~685.00 € | Fri 22 Nov 24 |
 | CCF642 REF: TM-T6800CAS: 346640-08-2 | 97.12% - 98.82% | 35.00 €~1,103.00 € | Fri 29 Nov 24 |
 | CCF-642 REF: 3D-WNA64008CAS: 346640-08-2 | Min. 95% | To inquire | Fri 03 Jan 25 |
Ref: IN-DA00C6L0
| 10mg | 67.00 € | ||
| 50mg | 139.00 € | ||
| 100mg | 172.00 € | ||
| 250mg | 302.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
CCF642
CAS:346640-08-2
CCF642 (AC1LYELL) is a novel PDI-inhibiting compound with antimyeloma activity.
Formula:
C15H10N2O4S3
Purity:
97.12% - 98.82%
Color and Shape:
Solid
Molecular weight:
378.45
Ref: TM-T6800
| 1mg | 35.00 € | ||
| 2mg | 51.00 € | ||
| 5mg | 83.00 € | ||
| 10mg | 101.00 € | ||
| 25mg | 193.00 € | ||
| 50mg | 343.00 € | ||
| 100mg | 496.00 € | ||
| 500mg | 1,103.00 € | ||
| 1mL*10mM (DMSO) | 70.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
CCF-642
CAS:346640-08-2
CCF-642 is a small molecule that inhibits the activity of hypoxia-inducible factor 1 (HIF-1) and …
Formula:
C15H10N2O4S3
Purity:
Min. 95%
Molecular weight:
378.45 g/mol
Ref: 3D-WNA64008
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Friday 3 Jan 2025
